LabGenomics has acquired 2 companies, including 2 in the last 5 years. A total of 1 acquisition came from private equity firms.
LabGenomics has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
700 Daewangpangyo-ro, Korea Bio Park Bldg. 6F-B,
Seongnam-si,
463-400
South Korea,
www.labgenomics.co.kr
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2024-10-25 |
IMD · Life Science
Berkeley, California · www.imdpath.com IMD specializes in molecular diagnostics and provides advanced technology and infrastructure to support community-based pathology and oncology practices, particularly in the field of cancer management. IMD is based in Berkeley, California. |
- | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
